Clinical Trial Update: Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial [NA]

View source ↗

Summary

Randomized clinical trial evaluating early DHA and ARA fatty acid supplementation in growth-restricted very preterm infants. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Failure to Thrive
• Intrauterine Growth Restriction
• Malnutrition in Infancy
• Premature Birth

Drugs mentioned

• Arachidonic acid (ARA) (Arachidonic acid)
• Docosahexaenoic acid (DHA) (docosahexaenoic acid)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Infant Malnutrition, Light-For-Dates With Signs of Fetal Malnutrition | NA | Status: RECRUITING